Summary of Significant Accounting Policies and Recently Issued Accounting Pronouncements - Additional Information (Details) - USD ($)		1 Months Ended	3 Months Ended
	Oct. 26, 2018	Mar. 28, 2018	Mar. 31, 2021	Dec. 31, 2020	Aug. 03, 2020
Basic And Diluted Earnings Per Share [Line Items]
Recognized grants receivable	$ 1,400,000
Restricted Cash			$ 50,000	$ 50,000
Maximum Research And Development Expenses Reimbursement		$ 200,000
Grants Receivable	1,800,000
Phase Two [Member]
Basic And Diluted Earnings Per Share [Line Items]
Grants Receivable in fiscal year	$ 1,100,000				$ 500,000
Grant Income Recognized			$ 100,000